Jade Biosciences, Inc. reports Q4 results [Seeking Alpha]
Jade Biosciences, Inc. (JBIO)
Company Research
Source: Seeking Alpha
As of December 31, 2025, Jade had cash, cash equivalents, and investments of $336.2 million. More on Jade Biosciences, Inc. Seeking Alpha's Quant Rating on Jade Biosciences, Inc. Historical earnings data for Jade Biosciences, Inc. Dividend scorecard for Jade Biosciences, Inc.
Show less
Read more
Impact Snapshot
Event Time:
JBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JBIO alerts
High impacting Jade Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
JBIO
News
- Jade Biosciences (JBIO) had its price target raised by BTIG Research from $28.00 to $39.00. They now have a "buy" rating on the stock.MarketBeat
- Jade Biosciences (JBIO) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- Jade Biosciences (JBIO) had its price target raised by Guggenheim from $17.00 to $23.00. They now have a "buy" rating on the stock.MarketBeat
- Jade Biosciences (JBIO) was upgraded by William Blair to "strong-buy".MarketBeat
- Jade Biosciences (JBIO) had its "outperform" rating reaffirmed by Wedbush. They now have a $24.00 price target on the stock.MarketBeat
JBIO
Earnings
- 11/13/25 - Beat
JBIO
Sec Filings
- 3/6/26 - Form S-8
- 3/6/26 - Form POS
- 3/6/26 - Form POS
- JBIO's page on the SEC website